Related Experiment Video
Updated: Aug 22, 2026

Quantitative Imaging of Lineage-specific Toll-like Receptor-mediated Signaling in Monocytes and Dendritic Cells from Small Samples of Human Blood
Published on: April 16, 2012
Relationship of aging and cardiac IL-10
Victoria Dotson1, Katherine Horak, Cory Alwardt
1The Circulatory Science Graduate Perfusion Program, Department of Surgery, College of Medicine, The University of Arizona, Tucson, Arizona 85724, USA.
Insights
Aging impairs heart regeneration after myocardial infarction by increasing Interleukin-10 (IL-10). This reduces stem cell proliferation, hindering repair. Modulating IL-10 may optimize cardiac healing in older patients.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Aging Biology
Background:
- Current heart failure and myocardial infarction therapies are limited by the inability of cardiac cells to regenerate.
- Stem cell therapy offers potential but faces challenges in stem cell recruitment and engraftment in damaged heart tissue.
- Age-related changes in the heart may impede the necessary molecular signaling for effective stem cell integration.
Purpose of the Study:
- To investigate the role of Interleukin-10 (IL-10) in age-related impairment of cardiac regeneration following myocardial injury.
- To test the hypothesis that elevated IL-10 in aged individuals reduces cardiac cellular proliferation and stem cell response after heart attack.
Main Methods:
- Analysis of cardiac gene expression in aging models and human myocardial infarction samples.
- Correlation of IL-10 levels with cellular proliferation in the border regions of infarcted myocardium.
- Review of existing literature on aging, IL-10, and tissue repair.
Main Results:
- Demonstrated increased cardiac gene expression of IL-10 in aged subjects.
- Observed a reduced proliferative response in the infarcted myocardium of older individuals, proportional to age.
- Found elevated IL-10 levels in aging models are linked to diminished healing responses in various tissues.
Conclusions:
- Overexpression of IL-10 in aged populations contributes to reduced cardiac cellular proliferation after myocardial infarction.
- Age-related increases in IL-10 may be a key factor limiting the regenerative capacity of the heart.
- Targeting IL-10 therapeutically could enhance stem cell engraftment and promote myocardial repair in elderly patients with heart conditions.
Abstract:
Current therapies for the treatment of myocardial infarction and heart failure include medical, surgical, mechanical assist, and transplantation. These therapies have been based on the dogma that ventricular myocytes themselves are terminally differentiated and, therefore, cannot regenerate. This concept has been recently challenged with stem cell therapy. A potential problem is the ability of cardiac tissue to mobilize, recruit, and transdifferentiate adult stem cells from other tissues. We believe that there is a unique failure of the damaged myocardium to provide the appropriate molecular signals for stem cells engraftment related to age. Our hypothesis is that the overexpression of IL-10 in the aged population reduces cardiac cellular proliferation subsequent to myocardial injury. This hypothesis is supported by aging models, where elevated levels of IL-10 are associated with reduced healing response to noncardiac tissue injury. We demonstrated an increased cardiac gene expression of IL-10 that may be associated with a reduced proliferative response in the border regions of the infarcted myocardium that are proportional with age. In conclusion, myocardial infarction and heart failure has presented a significant challenge for the clinician to provide reparative therapies. The use of therapeutics to modulate IL-10 and, thereby, optimizing regenerative processes in the injured myocardium may provide a unique means for the cardiac patient.
Related Concept Videos
The Effect of Aging on Tissues
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
